Dexcom, Inc. Stock Performance
as on March 21, 2026 at 6:59 am IST
Day's Low
Day's High
$66.00$67.91
1.39%
Downside
1.46%
Upside
52 Week's Low
52 Week's High
$54.11$89.9819.15%
Downside
34.44%
Upside
Dexcom, Inc. share price movements today
- Previous Close
- $67.27
- Open
- $67.42
- Volume
- 2.3M
- Day's Low - High
- $66.00 - $67.91
- 52 Week Low - High
- $54.11 - $89.98
Dexcom, Inc. Historical Returns
- 1 Month Return
- -8.39 %
- 3 Month Return
- + 1.35 %
- 1 Year Return
- -9.28 %
- 3 Year Return
- -43.73 %
- 5 Year Return
- -22.29 %
Dexcom, Inc. Stock Fundamentals & Key Indicators
Check Dexcom, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$26.1B
EPS (TTM)
2.4973
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.78%
PE Ratio (TTM)
32.19
Industry PE ratio
17.63179487179487
PEG Ratio
0.9876
EBITDA
1.2B
Revenue (TTM)
4.7B
Profit Margin
17.94%
Return On Equity TTM
34.50%
Dexcom, Inc. Stock Valuation
Track how Dexcom, Inc. P/E has moved over time to understand its valuation trends.
Dexcom, Inc. in the last 5 years
Lowest (30.93x)
December 31, 2025
Industry (17.63x)
March 21, 2026
Today (32.19x)
March 21, 2026
Highest (175.15x)
September 30, 2021
Today’s Price to Earnings Ratio: 32.19x
Dexcom, Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Dexcom, Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $26.1B | -22.29% | 32.19 | 17.94% | |
| BUY | $103.7B | 82.03% | 36.03 | 14.44% | |
| BUY | $130.0B | 45.94% | 40.5 | 12.92% | |
| BUY | $186.3B | -12.3% | 28.81 | 14.72% | |
| BUY | $111.5B | -26.12% | 24.27 | 13.00% |
Stock Returns calculator for Dexcom, Inc. Stock including INR - Dollar returns
The Dexcom, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Dexcom, Inc. investment value today
Current value as on today
₹99,595
Returns
Returns from Dexcom, Inc. Stock
Dollar Returns*
₹8,904 (+8.9%)
Analyst Recommendation on Dexcom, Inc. Stock
Based on 30 analysts
86.67%
Buy
13.33%
Hold
0.00%
Sell
Based on 30 analysts, 86.67% of analysts recommend a 'BUY' rating for Dexcom, Inc.. Average target price of $86.12
Dexcom, Inc. Share Price Target
Get share price movements and forecasts by analysts on Dexcom, Inc..
What analysts predicted
22.28%UPSIDE
Target Price
$86.12
Current Price
$66.93
Analyzed by
30 Analysts
Target
$86.12
Dexcom, Inc. target price $86.12, a slight upside of 22.28% compared to current price of $66.93. According to 30 analysts rating.
Dexcom, Inc. Stock’s Investor Sentiment and Interest
Search interest for Dexcom, Inc. Stock has decreased by -14% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Dexcom, Inc. Quarterly Profit & Loss
All numbers in Millions USD
Dexcom, Inc. Annual Profit & Loss
All numbers in Millions USD
Dexcom, Inc. Quarterly Cash Flow
All numbers in Millions USD
Dexcom, Inc. Annual Cash Flow
All numbers in Millions USD
Mutual Funds that own Dexcom, Inc. Stock
Check out the Mutual Funds with significant holdings in Dexcom, Inc..
Funds | Holdings | Shares Held |
|---|---|---|
 Motilal Oswal S&P 500 Index Fund Direct Growth | 0.04811% | 2919 |
 ICICI Prudential NASDAQ 100 Index Fund Direct Growth | 0.15385% | 6452 |
Global Institutional Holdings in Dexcom, Inc.
Dexcom, Inc. News & Key Events
Today's Timeline - 13 February
Fri, 05:31 PM
-DexCom reports strong Q4 2025 results, with revenue of $1.26 billion and adjusted earnings of $0.68 per share.
Fri, 10:01 PM
-DexCom shares jump 7.3% after beating revenue and earnings estimates, despite guidance aligning with analyst expectations.
Fri, 11:16 PM
-DexCom maintains 2026 revenue guidance of $5.16 billion to $5.25 billion after strong Q4 performance.
Insights on Dexcom, Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Dexcom, Inc. has demonstrated strong revenue growth over the last four quarters, increasing from $1.03 billion to $1.25 billion. This translates to an average revenue increase of 6.3% per quarter.
- POSITIVE IMPACT
Price Rise
In the last 7 days, DXCM stock has moved up by 4.2%
NO EFFECTAgainst Peers
In the last 1 year, Edwards Lifesciences Corp. has given 17.1% return, outperforming this stock by 26.4%
- NO EFFECT
Against Peers
In the last 3 years, Boston Scientific Corp. has given 3.9% return, outperforming this stock by 45.7%
NEGATIVE IMPACTProfit Down
Dexcom, Inc. has experienced a decline in its net profit for the last two quarters. The net profit decreased from $283.8 million to $267.3 million, which represents an average decrease of 5.8% per quarter.
About Dexcom, Inc.
| Organisation | Dexcom, Inc. |
| Headquarters | 6340 Sequence Drive, San Diego, CA, United States, 92121 |
| Industry | Health Technology |
| CEO | Mr. Jacob Steven Leach |
| E-voting on shares | Click here to vote |
Key Management of Dexcom, Inc.
Name | Title |
|---|---|
Mr. Girish Naganathan | Executive VP & CTO |
Mr. Matthew Dolan | Executive Vice President of Strategy & Corporate Development |
Mr. Donald M. Abbey | Executive Vice President of Global Business Services, Regulatory, Medical & Clinical Affairs |
Mr. Jon Coleman | Executive VP & Chief Commercial Officer |
Mr. Kevin Ronald Sayer | Executive Chairman of the Board |
Mr. Jacob Steven Leach | President, CEO & Director |
Ms. Sadie M. Stern | Executive VP & Chief Human Resources Officer |
Mr. Jereme M. Sylvain CPA | Executive VP, CFO & Chief Accounting Officer |
Mr. Michael Jon Brown | Executive VP & Chief Legal Officer |
Mr. Sean Christensen | Vice President of Finance and Investor Relations |
FAQs
What is Dexcom, Inc. share price today?
Dexcom, Inc. share price today is $66.93 as on at the close of the market. Dexcom, Inc. share today touched a day high of $67.91 and a low of $66.
What is the 52 week high and 52 week low for Dexcom, Inc. share?
Dexcom, Inc. share touched a 52 week high of $89.98 on and a 52 week low of $54.11 on . Dexcom, Inc. stock price today i.e. is closed at $66.93,which is 25.62% down from its 52 week high and 23.69% up from its 52 week low.
What is Dexcom, Inc.'s market capitalisation today?
Dexcom, Inc. market capitalisation is $0.03T as on .
How to invest in Dexcom, Inc. Stock (DXCM) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Dexcom, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Dexcom, Inc. Shares that will get you 0.0224 shares as per Dexcom, Inc. share price of $66.93 per share as on March 21, 2026 at 1:29 am IST.
What is the minimum amount required to buy Dexcom, Inc. Stock (DXCM) from India?
Indian investors can start investing in Dexcom, Inc. (DXCM) shares with as little as ₹93.652 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹936.52 in Dexcom, Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Dexcom, Inc. share’s latest price of $66.93 as on March 21, 2026 at 1:29 am IST, you will get 0.1494 shares of Dexcom, Inc.. Learn more about
fractional shares .
What are the returns that Dexcom, Inc. has given to Indian investors in the last 5 years?
Dexcom, Inc. stock has given -22.29% share price returns and 28.67% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?